{{Drugbox
| verifiedrevid = 443223982
| IUPAC_name = (1''R'')-&#x200b;''N''-&#x200b;ethyl-&#x200b;2-&#x200b;phenyl-&#x200b;1-&#x200b;[(2''R'')-&#x200b;tetrahydrofuran-&#x200b;2-&#x200b;yl]&#x200b;ethanamine
| image = Zylofuramine.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 3563-92-6
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 71129
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64277
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8N66VC535R

<!--Chemical data-->
| C=14 | H=21 | N=1 | O=1 
| molecular_weight = 219.32264 g/mol
| smiles = O2[C@@H]([C@H](NCC)Cc1ccccc1)CCC2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H21NO/c1-2-15-13(14-9-6-10-16-14)11-12-7-4-3-5-8-12/h3-5,7-8,13-15H,2,6,9-11H2,1H3/t13-,14-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DOFCLOLKFGSRTG-ZIAGYGMSSA-N
}}

'''Zylofuramine'''<ref>{{ cite patent | country = US | status = patent | number = 3091621 | inventor = Clarke, R. L. | gdate = 1963-05-28 | assign1 = Sterling Drugs | title = Alpha-Aryl or Aralkyl Tetrahydrofurfurylamines }}</ref>  is a [[stimulant]] drug. It was developed in 1961,<ref>{{Cite journal 
| last1 = Clarke | first1 = R. L. 
| last2 = Harris | first2 = L. S. 
| title = α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. I 
| journal = Journal of Medicinal Chemistry 
| volume = 5
| issue = 1 
| pages = 77–95 
| year = 1962 
| doi = 10.1021/jm01236a010
| pmid = 14046619
}}</ref><ref>{{Cite journal 
| last1 = Clarke | first1 = R. L. 
| last2 = Tullar | first2 = B. F. 
| last3 = Harris | first3 = L. S. 
| title = α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. II. Resolution of Isomers 
| journal = Journal of Medicinal Chemistry 
| volume = 5
| issue = 2
| pages = 362–372 
| year = 1962 
| doi = 10.1021/jm01237a014
| pmid = 14051912
}}</ref> and was intended for use as an [[appetite suppressant]] and for the treatment of [[senile dementia]] in the elderly, but there is little information about it and it does not appear to have ever been marketed.<ref>{{ cite journal |author1=Harris, L. S. |author2=Clarke, R. L. |author3=Dembinski, J. R. | title = α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. III. The Pharmacology of D-Threo α-Benzyl-N-Ethyltetrahydrofurfurylamine (Zylofuramine) | journal = Archives Internationales de Pharmacodynamie et de Thérapie | year = 1963 | volume = 146 | pages = 392–405 | pmid = 14099588 }}</ref>

Zylofuramine is legal throughout the world. Its [[chemical structure]] has a vague similarity to other N-ethyl substituted stimulant drugs such as [[ethylamphetamine]], but its structure would probably not be close enough for it to be considered a [[Designer drug|controlled substance analogue]].

== References ==
{{Reflist}}

{{Stimulants}}
{{Anorectics}}
{{Monoamine releasing agents}}
{{Phenethylamines}}

[[Category:Stimulants]]
[[Category:Tetrahydrofurans]]
[[Category:Phenethylamines]]
[[Category:Norepinephrine-dopamine releasing agents]]


{{nervous-system-drug-stub}}